Claudia von Schilling Prize for outstanding achievements

Our PI Kirsten Kübler was recognized by the Claudia von Schilling Foundation for her work on tamoxifen in the development of sporadic uterine cancers, and for providing “concrete impetus for improving treatment safety” and combining “fundamental findings with a clear perspective for patients.”